News
NDRA
--
0.00%
--
ENDRA Life Sciences to Attend Lake Street's Fourth Annual Best Ideas Growth (BIG4) Conference September 17, 2020
ANN ARBOR, MI / ACCESSWIRE / September 15, 2020 / ENDRA Life Sciences Inc.
ACCESSWIRE · 09/15 13:00
ENDRA Life Sciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 16, 2020
ANN ARBOR, MI / ACCESSWIRE / September 14, 2020 / ENDRA Life Sciences Inc.
ACCESSWIRE · 09/14 14:00
How Should Investors React To ENDRA Life Sciences' (NASDAQ:NDRA) CEO Pay?
Francois Michelon has been the CEO of ENDRA Life Sciences Inc. (NASDAQ:NDRA) since 2015, and this article will examine...
Simply Wall St. · 09/08 17:18
ENDRA Life Sciences to Present at the LD Micro 500 Virtual Conference
ANN ARBOR, MI / ACCESSWIRE / September 2, 2020 / ENDRA Life Sciences Inc.
ACCESSWIRE · 09/02 20:00
(LD Micro) 360 Companies Set to Present this Week
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
ACCESSWIRE · 08/31 22:00
ENDRA Life Sciences to showcase TAEUS(R) Technology at EASL International Liver Congress 2020
ANN ARBOR, MI / ACCESSWIRE / August 27, 2020 / ENDRA Life Sciences Inc.
ACCESSWIRE · 08/27 14:00
ENDRA Life Sciences To Showcase TAEUS Technology At EASL International Liver Congress 2020
ANN ARBOR, MI / ACCESSWIRE / August 27, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), is exhibiting at The Digital International
Benzinga · 08/27 13:01
ENDRA Life Sciences To Receive $5M From Early Warrant Exercises
ANN ARBOR, MI / ACCESSWIRE / August 24, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced certain shareholders have
Benzinga · 08/24 13:03
ENDRA Life Sciences Inc.'s (NDRA) CEO Francois Michelon on Q2 2020 Results - Earnings Call Transcript
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q2 2020 Results Earnings Conference Call August 17, 2020, 4:30 PM ET Company Participants David Wells - Chief Financial Officer Francois Michelon - Chairman and CEO Renaud Maloberti - Chief Commercial Officer Michael Thornton - Chief Technology Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Vernon Bernardino - H.C.
Seeking Alpha - Transcript · 08/17 23:21
Endra Life Sciences EPS misses by $0.01
Endra Life Sciences (NDRA): Q2 GAAP EPS of -$0.31 misses by $0.01.Cash balance of ~$0.75M on June 30, and $2.4M as of August 14.Press Release
Seekingalpha · 08/17 21:46
ENDRA nabs European patent covering its ultrasound system
ENDRA Life Sciences (NDRA -0.4%) has been issued European Patent 3328285 from the European Patent Office, for its Thermo Acoustic Enhanced UltraSound (TAEU
seekingalpha · 07/22 21:16
ENDRA Live Sciences Granted Additional European Patent As Commercialization Begins
Benzinga · 07/22 13:06
ENDRA Life Sciences Submits 510(k) Application To FDA For TAEUS Liver Device
Benzinga · 06/30 12:17
ENDRA Life Sciences Announces Addition Of New Patents
Two Newly Issued Patents Further Protect ENDRA's TAEUS Platform Capabilities ANN ARBOR, MI / ACCESSWIRE / June 23, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a
Benzinga · 06/23 12:20
ENDRA Life Sciences' NASH Test Device, TAEUS, At Commercialization Inflection Point
Seeking Alpha - Article · 06/20 00:40
ENDRA Life teams up with Medical College of Wisconsin for TAEUS device
Seeking Alpha - Article · 06/08 14:21
ENDRA Life Sciences Announces New Clinical Study Partnership with the Medical College of Wisconsin
Benzinga · 06/08 12:09
ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/16 17:46
Earnings Scheduled For May 14, 2020
Companies Reporting Before The Bell Melco Resorts & Entertainment Limited (NASDAQ: MLCO) is estimated to report quarterly loss at $0.43 per share on revenue of $649.91 million.
Benzinga · 05/14 09:03
The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 6.)
Benzinga · 04/07 11:57
Webull provides a variety of real-time NDRA stock news. You can receive the latest news about ENDRA Life through multiple platforms. This information may help you make smarter investment decisions.
About NDRA
ENDRA Life Sciences Inc. is engaged in commercialization of an enhanced ultrasound technology for the pre-clinical research market. The Company's Nexus 128 system combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in pre-clinical applications. The Company is involved in developing Thermo Acoustic Enhanced Ultrasound (TAEUS) for incorporation into new ultrasound systems. The TAEUS platform has capabilities and potential clinical applications, such as enabling ultrasound to distinguish fat from lean tissue; enabling traditional ultrasound to visualize changes in tissue temperature, in real time; enabling ultrasound to view blood vessels from any angle, using only a saline solution contrasting agent, unlike Doppler ultrasound which requires precise viewing angles, and enabling ultrasound to image blood flow at the capillary level in a region, organ or tissue.
More